Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04223102 · ClinicalTrials.gov registry record · NA
Microbiome and Rectal Cancer
A NA study of Rectal Cancer and Locally Advanced Malignant Neoplasm, sponsored by University of South Florida.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 3
- Study locations
NCT04223102: Active NA study of Rectal Cancer and Locally Advanced Malignant Neoplasm, sponsored by University of South Florida.
NCT04223102 is a NA study of Rectal Cancer and Locally Advanced Malignant Neoplasm that is active but no longer recruiting, run by University of South Florida. The registered enrollment target is 40 participants, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04223102, a NA study of Rectal Cancer and Locally Advanced Malignant Neoplasm, is active but no longer recruiting, sponsored by University of South Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of our study is to determine if an association exists between the microbiome of those with rectal adenocarcinoma who are complete pathologic responders and those who have a partial or no response to neoadjuvant therapy.
Primary Outcome
16s rRNA sequencing from biopsy specimens
Conditions Studied
Interventions
- PROCEDURE Tissue collection
Study Locations (3)
Florida
- Tampa General Hospital - Tampa
- University of South Florida - South Tampa Campus - Tampa
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2027-06 |
| Phase | NA |
What the registry record for NCT04223102 still lists
NCT04223102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Rectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Tissue collection is the first listed.
NCT04223102 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04223102 about?
NCT04223102 is a clinical study titled "Microbiome and Rectal Cancer". The purpose of our study is to determine if an association exists between the microbiome of those with rectal adenocarcinoma who are complete pathologic responders and those who have a partial or no response to neoadjuvant therapy.
What is the current status of trial NCT04223102?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-02-18. Estimated completion is 2027-06.
What conditions does trial NCT04223102 study?
This clinical trial studies the following conditions: Rectal Cancer, Locally Advanced Malignant Neoplasm.
What interventions are being tested in trial NCT04223102?
The interventions under investigation include: Tissue collection (PROCEDURE).
Who is sponsoring clinical trial NCT04223102?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04223102 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04223102's enrollment target sits among peer trials
40 47th of 70 higher than 23 of 70 other Rectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
RECRUITING · NA
-
Resilience and Equity in Aging, Cancer, and Health (REACH)
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy